{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:22:11Z","timestamp":1787458931422,"version":"build-2736575974"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21 CA277849"],"award-info":[{"award-number":["R21 CA277849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R21 CA277849"],"award-info":[{"award-number":["R21 CA277849"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>Background: Emergency department (ED) use for cancer-related pain is common, particularly among patients with metastatic disease who frequently require opioid analgesia. In October 2014, the U.S. Drug Enforcement Administration rescheduled hydrocodone combination products from Schedule III to Schedule II, introducing stricter prescribing and dispensing requirements. We evaluated whether hydrocodone rescheduling was associated with pain-related ED visits and hospitalizations among older adults with metastatic lung cancer. Methods: We conducted a retrospective SEER\u2013Medicare cohort study of beneficiaries aged 66 years or older diagnosed with metastatic lung cancer. Diagnoses from January 2011 through September 2014 were classified as pre-policy, October 2014 was excluded as a transition month, and November 2014 through December 2018 constituted the post-policy period. Monthly 365-day cumulative incidences were estimated using the Aalen\u2013Johansen estimator with death treated as a competing event. Segmented interrupted time-series models estimated immediate level and slope changes. Adjusted cause-specific Cox models evaluated time to first event. Results: The cohort included 52,371 beneficiaries. For narrowly defined neoplasm-related pain ED visits, the policy was associated with an immediate increase of 0.834 percentage points (95% CI, 0.330\u20131.338) and a post-policy slope increase of 0.030 percentage points per month (95% CI, 0.011\u20130.049). Pain-related hospitalizations increased immediately by 0.946 percentage points (95% CI, 0.336\u20131.556), with a slope increase of 0.024 percentage points per month (95% CI, 0.005\u20130.042). At 12 months, fitted cumulative incidences exceeded no-policy projections by 1.193 percentage points for ED visits and 1.228 percentage points for hospitalizations. Adjusted cause-specific hazard ratios were 1.14 for pain-related ED visits (95% CI, 1.00\u20131.30; p = 0.054) and 1.14 for hospitalizations (95% CI, 1.00\u20131.29; p = 0.049). Conclusions: Hydrocodone rescheduling was temporally associated with modest increases in acute-care encounters explicitly coded for neoplasm-related pain. The findings underscore the importance of preserving timely analgesic access for patients with advanced cancer.<\/jats:p>","DOI":"10.3390\/curroncol33080495","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:14:01Z","timestamp":1787300041000},"page":"495","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain-Related Emergency Department Visits and Hospitalizations Following Hydrocodone Rescheduling in Metastatic Lung Cancer"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5680-3134","authenticated-orcid":false,"given":"Chan","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA"},{"name":"Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA"},{"name":"Penn State Cancer Institute, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ikram","sequence":"additional","affiliation":[{"name":"Department of Surgery, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-5047","authenticated-orcid":false,"given":"Shouhao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA"},{"name":"Penn State Cancer Institute, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Economics, Rutgers University, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-4610","authenticated-orcid":false,"given":"Douglas","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6017-7500","authenticated-orcid":false,"given":"James Douglas","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX 77204, USA"},{"name":"Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston College of Pharmacy, Houston, TX 77204, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ajem.2018.03.025","article-title":"National characteristics of Emergency Department visits by patients with cancer in the United States","volume":"36","author":"Hsu","year":"2018","journal-title":"Am. J. Emerg. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e172450","DOI":"10.1001\/jamaoncol.2017.2450","article-title":"Trends in adult cancer\u2013related emergency department utilization: An analysis of data from the nationwide emergency department sample","volume":"3","author":"Rivera","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2250423","DOI":"10.1001\/jamanetworkopen.2022.50423","article-title":"Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US","volume":"6","author":"Tabriz","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e190979","DOI":"10.1001\/jamanetworkopen.2019.0979","article-title":"Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments","volume":"2","author":"Caterino","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pmn.2021.01.018","article-title":"Hospital admissions associated with cancer pain in older adults with and without dementia","volume":"22","author":"Strassels","year":"2021","journal-title":"Pain Manag. Nurs."},{"key":"ref_6","first-page":"381","article-title":"Current aproach to cancer pain management: Availability and implications of different treatment options","volume":"3","author":"Nersesyan","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.31303","article-title":"Cancer pain management and the opioid crisis in America: How to preserve hard-earned gains in improving the quality of cancer pain management","volume":"124","author":"Paice","year":"2018","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","article-title":"Expert panel consensus on management of advanced cancer\u2013related pain in individuals with opioid use disorder","volume":"4","author":"Merlin","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.06-1233","article-title":"Prevalence and predictors of symptoms in the terminal stage of lung cancer: A community study","volume":"131","author":"Skaug","year":"2007","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/curroncol30030262","article-title":"Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis","volume":"30","author":"Tan","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_11","unstructured":"World Health Organization (2018). WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents, World Health Organization."},{"key":"ref_12","unstructured":"Drug Enforcement Administration DoJ (2014). Schedules of controlled substances: Rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule. Fed. Regist., 79, 49661\u201349682."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jpainsymman.2020.06.015","article-title":"Cancer patients\u2019 perceived difficulties filling opioid prescriptions after receiving outpatient supportive care","volume":"60","author":"Brown","year":"2020","journal-title":"J. Pain Symptom Manag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.japh.2020.09.013","article-title":"Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review","volume":"61","author":"Usmani","year":"2021","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US trends in opioid access among patients with poor prognosis cancer near the end-of-life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_16","unstructured":"(2026, July 26). Surveillance, Epidemiology, and End Results, Available online: https:\/\/seer.cancer.gov\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.annepidem.2007.03.011","article-title":"A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients","volume":"17","author":"Klabunde","year":"2007","journal-title":"Ann. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"ref_19","unstructured":"Centers for Medicare & Medicaid Services (2026, July 25). Chemotherapy Measure (OP-35): Admissions and Emergency Department Visits for Patients Receiving Outpatient Chemotherapy. QualityNet, Available online: https:\/\/qualitynet.cms.gov\/outpatient\/measures\/chemotherapy\/methodology."},{"key":"ref_20","unstructured":"National Cancer Institute (2025, October 29). Comorbidity SAS Macro (2021 Version), Available online: https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/macro-2021.html."},{"key":"ref_21","first-page":"459","article-title":"Are cancer pain and depression interdependent? A systematic review","volume":"18","author":"Laird","year":"2009","journal-title":"Psycho-Oncol. J. Psychol. Soc. Behav. Dimens. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1136\/bmjspcare-2018-001533","article-title":"Depression and survival outcomes after emergency department cancer pain visits","volume":"9","author":"Reyes","year":"2019","journal-title":"BMJ Support. Palliat. Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"ref_24","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: A tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Turner, S.L., Forbes, A.B., Karahalios, A., Taljaard, M., and McKenzie, J.E. (2021). Evaluation of statistical methods used in the analysis of interrupted time series studies: A simulation study. BMC Med. Res. Methodol., 21.","DOI":"10.1186\/s12874-021-01364-0"},{"key":"ref_26","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand. J. Stat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Newey, W.K., and West, K.D. (1986). A Simple, Positive Semi-Definite, Heteroskedasticity and Autocorrelationconsistent Covariance Matrix, National Bureau of Economic Research.","DOI":"10.3386\/t0055"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/pds.5603","article-title":"The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths","volume":"32","author":"Karami","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","article-title":"Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis","volume":"51","author":"Hochstenbach","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1594","DOI":"10.1200\/OP.22.00251","article-title":"Manifestations of opioid stigma in patients with advanced cancer: Perspectives from patients and their support providers","volume":"18","author":"Bulls","year":"2022","journal-title":"JCO Oncol. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/oncolo\/oyad161","article-title":"Drivers of emergency department use among oncology patients in the era of novel cancer therapeutics: A systematic review","volume":"28","author":"Fleshner","year":"2023","journal-title":"Oncologist"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1200\/OP.24.00160","article-title":"Assessing the validity of the centers for Medicare & Medicaid Services measure in identifying potentially preventable emergency department visits by patients with cancer","volume":"21","author":"Turner","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non\u2013small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/495\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:12:14Z","timestamp":1787458334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/8\/495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["curroncol33080495"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33080495","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}